509
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib

, , &
Pages 2187-2198 | Published online: 15 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kwong-Fai Wong, Zhi Xu, Jinfei Chen, Nikki P Lee & John M Luk. (2013) Circulating markers for prognosis of hepatocellular carcinoma. Expert Opinion on Medical Diagnostics 7:4, pages 319-329.
Read now

Articles from other publishers (10)

Peiying Yang, Yan Jiang, Yong Pan, Xiaoping Ding, Patrea Rhea, Jibin Ding, David H. Hawke, Dean Felsher, Goutham Narla, Zhimin Lu & Richard T. Lee. (2019) Mistletoe extract Fraxini inhibits the proliferation of liver cancer by down-regulating c-Myc expression. Scientific Reports 9:1.
Crossref
Jin-Long Hu, Xin-Long Hu, Ai-Ye Guo, Chao-Jie Wang, Yi-Yang Wen & Shun-Dong Cang. (2017) Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells. Oncotarget 8:30, pages 49380-49394.
Crossref
Kentaro Fujiwara, Keitaro Koyama, Kosuke Suga, Masako Ikemura, Yasutaka Saito, Akihiro Hino, Hiroko Iwanari, Osamu Kusano-Arai, Kenichi Mitsui, Hiroyuki Kasahara, Masashi Fukayama, Tatsuhiko Kodama, Takao Hamakubo & Toshimitsu Momose. (2014) A 90Y-labelled anti-ROBO1 monoclonal antibody exhibits antitumour activity against hepatocellular carcinoma xenografts during ROBO1-targeted radioimmunotherapy. EJNMMI Research 4:1.
Crossref
Nian‐Kang Sun, Shang‐Lang Huang, Ting‐Chang Chang & Chuck C.‐K. Chao. (2013) Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk‐1‐dependent Mcl‐1 transcription and inducing Akt/GSK3β‐dependent protein degradation. Journal of Cellular Biochemistry 114:8, pages 1819-1831.
Crossref
Alex Y. Chang & Miao Wang. (2013) In-vitro growth inhibition of chemotherapy and molecular targeted agents in hepatocellular carcinoma. Anti-Cancer Drugs 24:3, pages 251-259.
Crossref
R. A. Pazo-Cid, M. Lanzuela, G. Esquerdo, J. L. Pérez-Gracia, A. Antón, G. Amigo, J. Martínez Trufero, A. L. García-Otín & P. Martín-Duque. (2012) Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC). Clinical and Translational Oncology 14:8, pages 564-574.
Crossref
Klaas Poelstra, Jai Prakash & Leonie Beljaars. (2012) Drug targeting to the diseased liver. Journal of Controlled Release 161:2, pages 188-197.
Crossref
Sameer H. Patel, Peter J. Kneuertz, Maria Delgado, David A. Kooby, Charles A. StaleyIIIIII, Bassel F. El-Rayes, John S. Kauh, Juan M. Sarmiento, Steven Hanish, Cynthia Cohen, Alton B. FarrisIIIIII & Shishir K. Maithel. (2011) Clinically Relevant Biomarkers to Select Patients for Targeted Inhibitor Therapy after Resection of Hepatocellular Carcinoma. Annals of Surgical Oncology 18:12.
Crossref
Zhiwei Wang, Hidefumi Fukushima, Daming Gao, Hiroyuki Inuzuka, Lixin Wan, Alan W. Lau, Pengda Liu & Wenyi Wei. (2011) The two faces of FBW7 in cancer drug resistance. BioEssays 33:11, pages 851-859.
Crossref
Stephanie Coulon, Femke Heindryckx, Anja Geerts, Christophe Van Steenkiste, Isabelle Colle & Hans Van Vlierberghe. (2011) Angiogenesis in chronic liver disease and its complications. Liver International 31:2, pages 146-162.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.